Clover Health (CLOV) Investments announced its 2026 Medicare Advantage offerings, “reinforcing Clover’s leadership in affordable, high-choice PPO plans that deliver real results for seniors and physicians alike as the Annual Enrollment Period opens,” the company said. “Many seniors are now navigating a landscape of fewer plan choices and rising costs. Our 2026 offerings are a direct reflection of our unwavering commitment to put their needs first,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “By preserving our PPO plans and enhancing our benefits, we are ensuring our members have the stability, choice predictability, and value they deserve, especially when others are pulling back.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
- Clover Health expands platform to third-party partners
- Clover Health ‘loses big’ in CMS star ratings, says Leerink
- Clover Health Announces 2026 Medicare Star Ratings
- Clover Health sees ‘strong’ above-market Medicare Advantage growth in FY26-27
- Counterpart Health announces AI chat for Counterpart Assisstant